Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14

Trial Status

Completed2
Recruiting1
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT06198296Phase 1Recruiting
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Embryonal Sarcoma of LiverHepatoblastomaHepatocellular Carcinoma+5 more
PrincipalinvestigatorStart date: 2025-06-10
NCT03762291Phase 1Completed
Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine
Multiple Myeloma
PrincipalinvestigatorStart date: 2021-08-06
NCT02494167Phase 1Completed
Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
Acute Myeloid LeukemiaMyelodysplastic Syndrome
PrincipalinvestigatorStart date: 2016-02-01
NCT04952584Phase 1Withdrawn
Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas
Classical Hodgkin LymphomaExtranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Steffin, MD

Baylor College of Medicine

Very Similar
4 trials

Shared therapeutic areas:

LiposarcomaMalignant Rhabdoid TumorRhabdomyosarcoma+5 more

Worked with same sponsors:

Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine
Collaborated on 1 trial
Similarity Score84%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteRhabdomyosarcomaWilms Tumor
Similarity Score7%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMultiple MyelomaMyelodysplastic Syndromes
Similarity Score7%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score7%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score7%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMultiple MyelomaMyelodysplastic Syndromes
Similarity Score7%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Classical Hodgkin LymphomaExtranodal Natural Killer/T-Cell Lymphoma, Nasal TypeRhabdomyosarcoma

Worked with same sponsors:

Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine+1 more
Similarity Score7%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Carcinoma, HepatocellularMultiple MyelomaRhabdomyosarcoma
Similarity Score7%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score5%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06198296Phase 1PrincipalInvestigator

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Embryonal Sarcoma of LiverHepatoblastomaHepatocellular Carcinoma+5 more
Recruiting
NCT03762291Phase 1PrincipalInvestigator

Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine

Multiple Myeloma
Completed
NCT02494167Phase 1PrincipalInvestigator

Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)

Acute Myeloid LeukemiaMyelodysplastic Syndrome
Completed
NCT04952584Phase 1PrincipalInvestigator

Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas

Classical Hodgkin LymphomaExtranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Withdrawn

All 4 trials loaded